|
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis Clinical research trials and A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis. A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis clinical trial. Subjects often receive the most expert healthcare possible for their A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis  A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
For Condition: Meningitis, Cryptococcal,HIV Infections
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: - Immunosuppressant therapy. - Antiviral therapy such as zidovudine. - Prophylaxis for Pneumocystis carinii pneumonia. Concurrent Treatment: Allowed: - Radiation therapy for mucocutaneous Kaposi's sarcoma. Written informed consent must be obtained for each patient, either from the patient himself or from the patient's legal guardian. - No prior systemic antifungal therapy for cryptococcosis. - Relapse after prior therapy. - Success of prior therapy must have been documented by negative cerebrospinal fluid (CSF) culture at the end of therapy. Following prior therapy, such patients may not have received more than 1 mg/kg/wk amphotericin B in the 4 weeks before entry into study. Prior Medication: Allowed: - Immunosuppressant therapy. - Antiviral therapy (such as zidovudine). - Prophylaxis for Pneumocystis carinii pneumonia. Exclusion Criteria Co-existing Condition: Patients with the following are excluded: - Evidence of acute or chronic meningitis based upon any etiology other than cryptococcosis. - History of allergy to or intolerance of imidazoles, azoles, or amphotericin B. - Moderate or severe liver disease. - Comatose. - Unlikely to survive more than 2 weeks. - Any exceptions to these prohibitions of concomitant medications must be approved by Pfizer Central Research. Concurrent Medication: Excluded: - Coumadin-type anticoagulants. - Oral hypoglycemics. - Barbiturates. - Phenytoin. - Immunostimulants. - Investigational drugs or approved (licensed) drugs for investigational indications. - Any exceptions to these prohibitions of concomitant medications must be approved by Pfizer Central Research. - Excluded within 4 weeks of study entry: - Greater than 1 mg/kg/wk amphotericin B. Concurrent Treatment: Excluded: - Lymphocyte replacement. Patients with the following are excluded: - Evidence of acute or chronic meningitis based upon any etiology other than cryptococcosis. - History of allergy to or intolerance of imidazoles, azoles, or amphotericin B. - Moderate or severe liver disease. - Comatose. - Unlikely to survive more than 2 weeks. Prior Medication: Excluded: - Coumadin-type anticoagulants. - Oral hypoglycemics. - Barbiturates. - Phenytoin. - Immunostimulants. - Investigational drugs or approved (licensed) drugs for investigational indications. - Excluded within 4 weeks of study entry: - Greater than 1 mg/kg/wk amphotericin B. Prior Treatment: Excluded: - Lymphocyte replacement.
Total Enrollment:
Location and Contact Information:
Univ of Tennessee
Memphis, Tennessee, 38163
United States
Albany Med College / AIDS Treatment Ctr
Albany, New York, 12203
United States
Univ Hosp
Boston, Massachusetts, 02118
United States
Harper Hosp
Detroit, Michigan, 48201
United States
Ann Arbor Veterans Administration Med Ctr
Ann Arbor, Michigan, 48105
United States
Univ of North Carolina School of Medicine
Chapel Hill, North Carolina, 275997215
United States
Louisiana State Univ School of Medicine
New Orleans, Louisiana, 70112
United States
Chelsea Village Med Ctr
New York City, New York, 10014
United States
Richmond AIDS Consortium
Richmond, Virginia, 23219
United States
Ohio State Univ Hosp
Columbus, Ohio, 43210
United States
Loch Raven Veterans Hosp
Baltimore, Maryland, 21218
United States
Univ of Alabama at Birmingham
Birmingham, Alabama, 35294
United States
United States Air Force Med Ctr
Lackland Air Force Base, Texas, 782365300
United States
New England Med Ctr
Boston, Massachusetts, 02111
United States
George Washington Univ Med Ctr
Washington D.C., District of Columbia, 20037
United States
Saint Michael's Hosp
Toronto, Ontario,
Canada
Tucson Veterans Administration Med Ctr
Tucson, Arizona, 85724
United States
Cincinnati Veterans Adm Med Ctr / Univ Hosp
Cincinnati, Ohio, 452670405
United States
Montefiore Med Ctr / Bronx Municipal Hosp
Bronx, New York, 10467
United States
Dr Michael Bach
Portland, Maine, 04102
United States
Mem Sloan - Kettering Cancer Ctr
New York City, New York, 10021
United States
UCLA CARE Ctr
Los Angeles, California, 90095
United States
Univ of South Florida
Tampa, Florida, 33612
United States
Henry Ford Hosp
Detroit, Michigan, 48202
United States
CHG-118 Group Health / Cooperative of Puget Sound
Seattle, Washington, 98112
United States
Columbia Univ
New York City, New York, 10032
United States
Northwestern Univ Med School
Chicago, Illinois, 60611
United States
Med College of Georgia
Augusta, Georgia, 30912
United States
Dr Martin Mass
San Francisco, California, 94120
United States
Saint Luke's - Roosevelt Hosp Ctr
New York City, New York, 10025
United States
Jewish Hosp Ctr Affiliation
Jamaica, New York, 11432
United States
Univ TX Galveston Med Branch
Galveston, Texas, 77550
United States
Tulane Univ School of Medicine
New Orleans, Louisiana, 70112
United States
Bronx Veterans Administration / Mount Sinai Hosp
Bronx, New York, 10468
United States
DeKalb Gen Hosp
Decatur, Georgia, 30033
United States
Dr Shelly Gordon
San Francisco, California, 94115
United States
Harlem AIDS Treatment Group / Harlem Hosp Ctr
New York City, New York, 10037
United States
Christiana Hosp / Med Ctr of Delaware
Wilmington, Delaware, 19899
United States
Emory Univ School of Medicine
Atlanta, Georgia, 30303
United States
Univ of Maryland / Inst of Human Virology
Baltimore, Maryland, 212011192
United States
Univ of Miami School of Medicine
Miami, Florida, 331361013
United States
Washington Univ School of Medicine
St. Louis, Missouri, 63108
United States
Dr Paul Rothman
Sherman Oaks, California, 91403
United States
Univ TX San Antonio Health Science Ctr
San Antonio, Texas, 78284
United States
Dr Daniel Barbaro
Dallas, Texas, 75235
United States
Additional Information:
Study ID Numbers: 012F; 056-159
Study Start Date:
Record last reviewed: December 1989
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002305
Other Meningitis, Cryptococcal Studies:
1. The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients with HIV and Cryptococcal Meningitis
2. A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
3. An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
4. SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
5. Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Related Studies:
Other Meningitis, Cryptococcal Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
|
|
|
|
|
|
|
|
